Published in Br Heart J on May 01, 1982
Caerphilly and Speedwell collaborative heart disease studies. The Caerphilly and Speedwell Collaborative Group. J Epidemiol Community Health (1984) 2.68
Insulin resistance, high prevalence of diabetes, and cardiovascular risk in immigrant Asians. Genetic or environmental effect? Br Heart J (1994) 1.47
Haemostatic factors associated with ischaemic heart disease in men aged 45 to 64 years. The Speedwell study. Br Heart J (1982) 1.31
Selenium and vitamin E in relation to risk factors for coronary heart disease. J Clin Pathol (1984) 1.15
High density lipoprotein cholesterol is not a major risk factor for ischaemic heart disease in British men. Br Med J (Clin Res Ed) (1986) 0.80
Lipid profile of a French-Canadian population: 1. Association of plasma lipid and lipoprotein levels with age, relative body weight and education. CMAJ (1985) 0.75
High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med (1977) 15.39
The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. Bull World Health Organ (1962) 10.43
Cardiorespiratory disease and diabetes among middle-aged male Civil Servants. A study of screening and intervention. Lancet (1974) 10.02
Indices of obesity derived from body weight and height. Br J Prev Soc Med (1967) 9.84
Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res (1970) 9.50
A random-zero sphygmomanometer. Lancet (1970) 9.40
Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease. Lancet (1975) 9.00
Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen. J Clin Pathol (1969) 5.94
The Tromsø heart-study. High-density lipoprotein and coronary heart-disease: a prospective case-control study. Lancet (1977) 5.10
Alcohol and blood lipids. The cooperative lipoprotein phenotyping study. Lancet (1977) 2.66
Risk factors for ischaemic heart-disease in normal men aged 40. Edinburgh-Stockholm Study. Lancet (1978) 2.32
Lipoprotein fractionation by a precipitation method. A simple quantitative procedure. Clin Chim Acta (1976) 2.19
Ischemic heart disease, atherosclerosis, and longevity. Circulation (1966) 2.03
High density lipoprotein cholesterol and incidence of coronary heart disease--the Israeli Ischemic Heart Disease Study. Am J Epidemiol (1979) 1.75
Enzymatic determinations of cholesterol in high-density-lipoprotein fractions prepared by a precipitation technique. Clin Chem (1976) 1.71
Multi-laboratory comparison of three heparin-Mn2+ precipitation procedures for estimating cholesterol in high-density lipoprotein. Clin Chem (1978) 1.63
An Anglo-American cardiovascular comparison. Lancet (1967) 1.63
Comparison of prevalence, case history and incidence data in assessing the potency of risk factors in coronary heart disease. Am J Epidemiol (1966) 1.56
High-density lipoprotein and coronary risk factors in normal men. Lancet (1979) 1.42
Human serum lipoproteins and their interrelationships. Adv Biol Med Phys (1967) 1.40
Distribution of triglyceride and total, LDL and HDL cholesterol in several populations: a cooperative lipoprotein phenotyping study. J Chronic Dis (1977) 1.31
Quantitative and qualitative serum lipoprotein analysis. Part 1. Studies in healthy men and women. Atherosclerosis (1975) 1.06
A micro-method for the rapid ultracentrifugal separation of human plasma high density lipoprotein subfractions, HDL2 and HDL3. Clin Chim Acta (1981) 0.91
Serum cholesterol and high density lipoprotein-cholesterol in coronary patients and healthy persons. Atherosclerosis (1979) 0.78
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet (1989) 9.27
Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease. Lancet (1975) 9.00
Frequency of risk factors for ischaemic heart-disease in a healthy British population. With particular reference to serum-lipoprotein levels. Lancet (1974) 8.19
Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet (1999) 7.30
Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS) Lancet (1992) 7.04
Blood lipid concentrations and other cardiovascular risk factors: distribution, prevalence, and detection in Britain. Br Med J (Clin Res Ed) (1988) 7.02
Radical SAM, a novel protein superfamily linking unresolved steps in familiar biosynthetic pathways with radical mechanisms: functional characterization using new analysis and information visualization methods. Nucleic Acids Res (2001) 6.49
Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies. Circulation (1991) 5.66
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
The Tromsø heart-study. High-density lipoprotein and coronary heart-disease: a prospective case-control study. Lancet (1977) 5.10
Strategies for reducing coronary heart disease and desirable limits for blood lipid concentrations: guidelines of the British Hyperlipidaemia Association. Br Med J (Clin Res Ed) (1987) 5.01
Knowledge-based indexing of the medical literature: the Indexing Aid Project. J Am Soc Inf Sci (1987) 4.15
Falls by elderly people at home: prevalence and associated factors. Age Ageing (1988) 3.92
A randomized controlled trial of acetyl salicylic acid in the secondary prevention of mortality from myocardial infarction. Br Med J (1974) 3.80
Technique to improve chronic motor deficit after stroke. Arch Phys Med Rehabil (1993) 3.50
Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families. Nat Genet (1994) 3.38
Lack of benefit of dietary advice to men with angina: results of a controlled trial. Eur J Clin Nutr (2003) 3.38
Screening of diabetics for retinopathy by ophthalmic opticians. Br Med J (Clin Res Ed) (1985) 3.28
The effect of intragenic recombination on the number of alleles in a finite population. Genetics (1978) 3.27
Structural relationships among Rhizobium meliloti symbiotic promoters. Cell (1983) 3.23
ARSACS, a spastic ataxia common in northeastern Québec, is caused by mutations in a new gene encoding an 11.5-kb ORF. Nat Genet (2000) 3.17
Learning of visceral and glandular responses. Science (1969) 3.13
The value of lowering cholesterol after myocardial infarction. N Engl J Med (1990) 3.10
Levels of customary physical activity among the old and the very old living at home. J Epidemiol Community Health (1988) 3.07
An open label study of the effects of rituximab in neuromyelitis optica. Neurology (2005) 2.99
Blind and partial sight registration in Avon. Br J Ophthalmol (1989) 2.88
Deliberate self-harm: clinical and socio-economic characteristics of 368 patients. Br J Psychiatry (1975) 2.87
Interaction between transcription factors Sp1 and YY1. Nature (1993) 2.87
Haplotype mapping and sequence analysis of the mouse Nramp gene predict susceptibility to infection with intracellular parasites. Genomics (1994) 2.80
Prevalence of carriers of premutation-size alleles of the FMRI gene--and implications for the population genetics of the fragile X syndrome. Am J Hum Genet (1995) 2.77
Premutation and intermediate-size FMR1 alleles in 10572 males from the general population: loss of an AGG interruption is a late event in the generation of fragile X syndrome alleles. Hum Mol Genet (2002) 2.77
Cytogenetic analysis of a segment of the Y chromosome of Drosophila melanogaster. Genetics (1984) 2.75
Long term follow up of women after hysterectomy with a history of pre-invasive cancer of the cervix. Br J Obstet Gynaecol (1992) 2.72
Parents' beliefs about vaccination: the continuing propagation of false contraindications. BMJ (1989) 2.71
Autoregulation of human thymidylate synthase messenger RNA translation by thymidylate synthase. Proc Natl Acad Sci U S A (1991) 2.67
Psychological markers in the detection of autism in infancy in a large population. Br J Psychiatry (1996) 2.64
C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men. Eur Heart J (2000) 2.59
Familial Wiedemann-Beckwith syndrome and a second Wilms tumor locus both map to 11p15.5. Am J Hum Genet (1989) 2.56
Trial of early nifedipine in acute myocardial infarction: the Trent study. Br Med J (Clin Res Ed) (1986) 2.55
Anxiety caused by a short-life hypnotic. Br Med J (Clin Res Ed) (1982) 2.51
Mechanisms of contrast agent destruction. IEEE Trans Ultrason Ferroelectr Freq Control (2001) 2.48
The hospital admissions study in England: are there alternatives to emergency hospital admission? J Epidemiol Community Health (1995) 2.46
Helicobacter pylori infection rates in relation to age and social class in a population of Welsh men. Gut (1991) 2.45
Global modulation of cellular transcription by human cytomegalovirus is initiated by viral glycoprotein B. Proc Natl Acad Sci U S A (2001) 2.44
Treatment of acquired aphasia: speech therapists and volunteers compared. J Neurol Neurosurg Psychiatry (1982) 2.43
Iron-deficiency anaemia: its effect on transfer factor for the lung (diffusiong capacity) and ventilation and cardiac frequency during sub-maximal exercise. Clin Sci (1972) 2.41
Cimetidine and HDL cholesterol. Lancet (1983) 2.40
Symptoms of iron deficiency anaemia. A community survey. Br J Prev Soc Med (1966) 2.35
Overfeeding rapidly induces leptin and insulin resistance. Diabetes (2001) 2.32
Dietary fatty acids and progression of coronary artery disease in men. Am J Clin Nutr (1996) 2.26
Performance-based physician reimbursement and influenza immunization rates in the elderly. The Primary-Care Physicians of Monroe County. Am J Prev Med (1998) 2.23
Controlled trial of a home-care service for acute stroke patients. Lancet (1985) 2.19
Lipoprotein fractionation by a precipitation method. A simple quantitative procedure. Clin Chim Acta (1976) 2.19
Further follow-up study of workers from an asbestos cement factory. Br J Ind Med (1982) 2.18
Cardiac surgery in Wessex: review of 1000 consecutive open-heart procedures. Br Med J (1976) 2.16
Antioxidant flavonols and ischemic heart disease in a Welsh population of men: the Caerphilly Study. Am J Clin Nutr (1997) 2.14
Aspirin and secondary mortality after myocardial infarction. Lancet (1980) 2.12
Gallbladder disease. Prevalence in a South Wales industrial town. N Engl J Med (1976) 2.12
A short dietary questionnaire for use in an epidemiological survey: comparison with weighed dietary records. Hum Nutr Appl Nutr (1983) 2.10
The Drosophila esc and E(z) proteins are direct partners in polycomb group-mediated repression. Mol Cell Biol (1998) 2.10
Effects of exposure to slate dust in North Wales. Br J Ind Med (1980) 2.09
Loss of vision before ophthalmic referral in blind and partially sighted diabetics in Bristol. Br J Ophthalmol (1994) 2.08
Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1. J Lipid Res (2000) 2.05
A Drosophila ESC-E(Z) protein complex is distinct from other polycomb group complexes and contains covalently modified ESC. Mol Cell Biol (2000) 2.05
A randomised controlled trial of the effect of the provision of free school milk on the growth of children. J Epidemiol Community Health (1980) 2.04
Atrial natriuretic factor in experimental cirrhosis in rats. Gastroenterology (1992) 2.03
The MD thesis in the training of a consultant physician. J R Coll Physicians Lond (1992) 2.03
A model for embryonal rhabdomyosarcoma tumorigenesis that involves genome imprinting. Proc Natl Acad Sci U S A (1989) 2.02
Evaluation of effects of unmodified niacin on fasting and postprandial plasma lipids in normolipidemic men with hypoalphalipoproteinemia. Am J Med (1994) 1.96
An operant approach to rehabilitation medicine: overcoming learned nonuse by shaping. J Exp Anal Behav (1994) 1.96
Reducing the risks of coronary heart disease in individuals and in the population. Lancet (1986) 1.95
Association between circulating haemoglobin level, serum-cholesterol, and blood-pressure. Lancet (1970) 1.94
Symptoms and circulating haemoglobin level. J Chronic Dis (1969) 1.93
Letter: High-density lipoprotein and atherosclerosis. Lancet (1975) 1.93
Family size and paternal unemployment in relation to myocardial infarction. J Epidemiol Community Health (1980) 1.93
Chronic hepatitis C with normal aminotransferase levels: a clinical histologic study. Am J Gastroenterol (1997) 1.91
Critical roles of kisspeptins in female puberty and preovulatory gonadotropin surges as revealed by a novel antagonist. Endocrinology (2009) 1.91
Absorption of vitamin D3-3H in control subjects and patients with intestinal malabsorption. J Clin Invest (1966) 1.88
Plasma triglyceride and high density lipoprotein cholesterol as predictors of ischaemic heart disease in British men. The Caerphilly and Speedwell Collaborative Heart Disease Studies. Br Heart J (1992) 1.88
Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis. Am Heart J (1987) 1.88
Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families. Am J Hum Genet (1998) 1.88
Acquired immune dysfunction in homosexual men: immunologic profiles. Clin Immunol Immunopathol (1983) 1.86
Family accommodation in obsessive-compulsive disorder. Am J Psychiatry (1995) 1.84